Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-29 @ 2:38 PM
Study NCT ID:
NCT01167335
Status:
WITHDRAWN
Last Update Posted:
2012-05-01
First Post:
2010-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures
Sponsor:
Novartis
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Partial Onset Seizures | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | partial onset seizure | View |
| None | seizure frequency | View |
| None | nervous system diseases | View |
| None | central nervous system diseases | View |
| None | CNS | View |
| None | brain diseases | View |
| None | neurologic manifestations | View |
| None | adjunctive treatment | View |
| None | AEDs | View |
| None | antiepileptic drug | View |